All News about Nevro Corp
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_10969.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/06/coinbase_global_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Where Nevro Stands With Analysts
May 31, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Looking Into Nevro's Return On Capital Employed
April 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
A Preview Of Nevro's Earnings
April 25, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/728930/crashing-arrow.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/06/thor_industries_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
5 Analysts Have This to Say About Nevro
April 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Nevro
February 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_8712.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/20/image21.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Where Nevro Stands With Analysts
January 26, 2023
Via Benzinga
Where Nevro Stands With Analysts
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/13/aapharma_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27941.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/20/nevro_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_6641.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/01/aapharma_8.png?width=1200&height=800&fit=crop)
Nevro Wins Multiple Coverage Options For Spinal Cord Stimulation In Diabetic Neuropathy
September 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2478.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/17/nvro_logo_light__4856fb71e61db2a6a3d0d00c1c5ebb8c.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
January 17, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_175.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_29.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_14981.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5443.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.